Add Formweb to your mobile device
Formulary synchronization in progress.
Please refer to Epic and your local
pharmacy
for available medications.
Search results for:
fentaNYL
fentaNYL
- Provider restrictions: Enrolled in REMS Program
- Patient restrictions: Transdermal patch is restricted to continuation of home therapy or conversion of oral therapy in opioid tolerant patients, defined as at least 60 mg of oral morphine daily (or equianalgesic dose of another opioid) for at least one week
Brand names: Abstral, FentaNYL Citrate, Fentora, Subsys
| Form | Strength |
|---|---|
| FILM, EXTENDED RELEASE, TRANSDERMAL | 12 mcg/hr; 25 mcg/hr; 37.5 mcg/hr; 50 mcg/hr; 62.5 mcg/hr; 75 mcg/hr; 87.5 mcg/hr; 100 mcg/hr |
| LOZENGE, ORAL TRANSMUCOSAL | 200 mcg; 400 mcg; 600 mcg; 800 mcg; 1200 mcg; 1600 mcg |
| SOLUTION, INJECTABLE | 5 mcg/mL-0.9%; 20 mcg/mL-0.9%; 50 mcg/mL |
| SPRAY, SUBLINGUAL | 100 mcg; 400 mcg; 600 mcg |
| TABLET, BUCCAL | 100 mcg; 200 mcg; 400 mcg; 600 mcg; 800 mcg |
| TABLET, SUBLINGUAL | 400 mcg |
VIEW MORE central nervous system agents, analgesics, narcotic analgesics
CLASS
CLASS
m00057, m00058, m00060
High Alert Drug
: Policy
Last updated: Mar. 1, 2024
- Black Box Warnings: Buccal Tablet: Serious adverse events, deaths; abuse potential
- Black Box Warnings: Nasal Spray: Schedule II Controlled Substance: Abuse potential
- Black Box Warnings: Sublingual Spray: Risk of respiratory depression, medication errors, abuse potential
- Black Box Warnings: Transdermal: High concentration of Schedule II opioid agonist
- Do Not Crush/Manipulate: Lozenge: Slow release. This lollipop delivery system requires the patient to dissolve it slowly.
- Do Not Crush/Manipulate: Sublingual tablet; do not suck, chew, or swallow whole
- Do Not Crush/Manipulate: Buccal tablet; swallowing whole or crushing may reduce effectiveness
- FDA REMS: View FDA REMS Info
- FDA REMS: FDA Med Guide Comprehensive List
Footnotes
Footnote A: Subsys® is restricted to providers who are actively enrolled in the TIRF REMS program
Policies and procedures
POLICY and PROCEDURE D-CNED-052 Pediatric Moderate and Deep Sedation in ED
PROCEDURE M-14.10 Anesthesia Pack for D6W C-Section And OB Patients
PROCEDURE M-19.3.a Epidural Pain Management
POLICY and PROCEDURE NU109_TMH Topical and Transdermal Medications
PCPS080_TMH Commonly Prescribed PRN Indications
Consults, protocols, and therapeutic interchanges
Additional information
Houston Methodist Pain Management page